To establish a causal connection between PEDF expression and endocrine resistance, we explored the functional consequences of PEDF silencing on tamoxifen sensitivity in endocrine-sensitive MCF-7 and T47D breast cancer cells. Here, SERPINF1 is linked to breast cancer.